Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMRX

Amneal Pharmaceuticals Inc

May 05 • 04:00PM ET

13.41

+0.30 2.29 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: JNJ PFE NVS TAK TEVA PRGO FMS RDY SNN

| Held by: IJR VTI VB IWM VBR VXF SPSM XSMO IWO DFAS

Scroll to Statements

Index	RUT	P/E	35.88	EPS (ttm)	0.37	Insider Own	51.61%	Shs Outstand	319.00M	Perf Week	5.30%
Market Cap	4.28B	Forward P/E	11.19	EPS next Y	1.20	Insider Trans	-0.11%	Shs Float	154.36M	Perf Month	8.58%
Enterprise Value	6.85B	PEG	0.62	EPS next Q	0.22	Inst Own	44.96%	Short Float	5.54%	Perf Quarter	-5.89%
Income	137.86M	P/S	1.40	EPS this Y	19.71%	Inst Trans	6.03%	Short Ratio	4.48	Perf Half Y	23.94%
Sales	3.05B	P/B	-	EPS next Y	20.64%	ROA	2.01%	Short Interest	8.56M	Perf YTD	6.43%
Book/sh	-0.23	P/C	21.64	EPS next 5Y	18.16%	ROE	-	52W High	15.42 -13.04%	Perf Year	77.85%
Cash/sh	0.62	P/FCF	17.74	EPS past 3/5Y	- -18.36%	ROIC	5.31%	52W Low	7.02 91.03%	Perf 3Y	598.44%
Dividend Est.	-	EV/EBITDA	11.00	Sales past 3/5Y	10.92% 8.66%	Gross Margin	36.55%	Volatility	3.46% 3.71%	Perf 5Y	131.61%
Dividend TTM	-	EV/Sales	2.25	EPS Y/Y TTM	160.50%	Oper. Margin	13.09%	ATR (14)	0.47	Perf 10Y	-58.44%
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	7.64%	Profit Margin	4.53%	RSI (14)	59.85	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.17	EPS Q/Q	405.32%	SMA20	3.69%	Beta	1.32	Target Price	17.00
Payout	0.00%	Debt/Eq	-	Sales Q/Q	3.97%	SMA50	4.50%	Rel Volume	0.67	Prev Close	13.11
Employees	8500	LT Debt/Eq	-	Earnings	Apr 22 BMO	SMA200	15.29%	Avg Volume	1.91M	Price	13.41
IPO	Dec 19, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.67% 0.40%	Trades		Volume	1,283,551	Change	2.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)